Delivery Order SPE2DE24D0021-SPE2D625F8CC0
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a $2,346.48 delivery order contract (Contract No. 4568797735) for MAGMAX Viral/Pathogen products by the Defense Department's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by August 5, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made on July 15, 2025, without any set-aside designation, reflecting Fisher Scientific's ability to compete...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,346.48 on September 26, 2025, for the MAGMAX VIRAL/PATHOGEN product line, with an ultimate completion date of October 20, 2025. This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, and is funded through the Defense Department's Medical Supply Chain division. The contract was awarded without any set-aside designation, indicating open competition. As a child contract,...
- Fisher Scientific Company L.L.C. was awarded a $5,279.58 fixed-price delivery order (Contract No. 4569344230) for MAGMAX Viral/Pathogen supplies by the Medical Supply Chain, a defense-focused federal agency. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was issued through open competition with no set-aside designation,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,173.24 on August 6, 2025, for the supply of MAGMAX viral/pathogen products to support the Medical Supply Chain, a defense-related federal agency. This fixed-price delivery order with economic price adjustment features will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 27, 2025. The award was made through open competition with no set-aside designation, demonstrating Fisher...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to Fisher Scientific Company L.L.C. on August 6, 2025, for direct polymerase chain reaction (PCR) reagents and kits, specifically MagMAX DNA products. This fixed-price delivery order with economic price adjustment carries a ceiling value of $1,952.64 and is scheduled for completion by August 18, 2025. The performance location is Pittsburgh, Pennsylvania. This award represents a child contract under a larger...
- This is a delivery order contract awarded by the Medical Supply Chain, a component of the Defense agency, to Fisher Scientific Company L.L.C., a for-profit limited liability company. The contract is for the purchase of the MAGMAX PATHOGEN RNA/DNA KIT, a specialized laboratory product, with a ceiling value of $4,572.00. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of April 1, 2025. The contract was not set aside for any specific...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Fisher Scientific Company L.L.C., a for-profit limited liability company and a major supplier of scientific products, equipment, and services to federal government agencies. The contract, valued at $9,748.79, is for the delivery of 4567963456 ! 5X MAGMAX PATHOGEN RNA/DNA KIT. This is a Delivery Order contract with a Fixed Price with Economic Price Adjustment pricing type, and the ultimate completion date is April 22,...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order contract valued at $1,173.24 by the Medical Supply Chain division of the Department of Defense on September 9, 2025, for MAGMAX viral/pathogen supplies. The contract is classified as a child award under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 30, 2025. No small business set-aside was utilized for this procurement, indicating the award was made...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,433.64 for DNA extraction and purification products utilizing the MagMAX technology platform. The contract, issued by the Defense Medical Supply Chain on August 6, 2025, represents a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by August 13, 2025. The work will be performed in Pittsburgh, Pennsylvania. This delivery order is issued under a larger contract vehicle and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Fisher Scientific Company L.L.C., a major supplier of scientific products, equipment, and services to federal government agencies. The $2,559.02 fixed-price delivery order is for the provision of 4568152568 MAGMAX PATHOGEN RNA/DNA KITs, which are laboratory testing supplies. This contract does not have a set-aside designation, indicating Fisher Scientific's ability to compete for open federal procurement opportunities....
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F8CC0Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order on July 22, 2025, for the procurement of 5X MAGMAX Pathogen RNA/DNA Kits with a ceiling value of $3,091.01. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of July 29, 2025. The contract will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through open competition with no set-aside designation, consistent with Fisher Scientific's typical federal procurement approach. Fisher Scientific, a major supplier of laboratory supplies, scientific instruments, and specialized testing solutions to federal agencies, is well-positioned to fulfill this pathogen detection requirement. The MAGMAX kits support molecular diagnostic capabilities, which align with the company's extensive experience providing advanced laboratory equipment and reagents across multiple federal departments and agencies, including the National Institutes of Health, Department of Veterans Affairs, and various defense-related organizations. The short performance timeline and relatively modest contract value indicate this is a targeted procurement to meet immediate testing needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/22/25 |